Loading financial statements…
Import this data to Google Sheets with:
=jivedata("LUMN","financials")Full statements spill as a table. For one cell: =jivedata("LUMN","Revenue") or =jivedata("LUMN","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
LUMN • CIK 0000018926
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $14,557,000 | $13,108,000 | $12,402,000 | $11,832,000 |
| Operating Income (Loss) | $-9,584,000 | $460,000 | $-812,000 | $198,000 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $-10,237,000 | $-230,000 | $-2,716,000 | $-1,400,000 |
| Income Tax Expense (Benefit) | $61,000 | $-175,000 | $-977,000 | $-376,000 |
| Net Income (Loss) Attributable to Parent | $-10,298,000 | $-55,000 | $-1,739,000 | $-1,024,000 |
| Cost of Goods and Services Sold | $7,144,000 | $6,703,000 | $6,638,000 | $6,177,000 |
| Selling, General and Administrative Expense | $3,198,000 | $2,972,000 | $3,199,000 | $3,342,000 |
| Gain (Loss) on Disposition of Business | $-121,000 | $-17,000 | $0 | $565,000 |
| Depreciation, Depletion and Amortization, Nonproduction | $2,985,000 | $2,956,000 | $2,749,000 | $2,680,000 |
| Goodwill, Impairment Loss | $10,693,000 | $0 | $628,000 | $0 |
| Costs and Expenses | $24,141,000 | $12,648,000 | $13,214,000 | $11,634,000 |
| InterestExpenseNonoperating | — | $1,372,000 | $1,284,000 | $1,025,000 |
| Gain (Loss) on Extinguishment of Debt | $618,000 | $348,000 | $-740,000 | $-689,000 |
| Other Nonoperating Income (Expense) | $-113,000 | $334,000 | $120,000 | $116,000 |
| Nonoperating Income (Expense) | $-653,000 | $-690,000 | $-1,904,000 | $-1,598,000 |
| Weighted Average Number of Shares Outstanding, Basic | 983,081,000 | 987,680,000 | 994,548,000 | 1,003,140,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $2,234,000 | $1,889,000 | $1,003,000 | $1,876,000 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $1,318,000 | $1,231,000 | $1,314,000 | $1,377,000 |
| Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization | — | — | $19,575,000 | $20,300,000 |
| Disposal Group, Including Discontinued Operation, Assets, Current | $104,000 | — | $4,285,000 | $0 |
| Other Assets, Current | $1,119,000 | $1,274,000 | $1,307,000 | $856,000 |
| Assets | $34,018,000 | $33,496,000 | $34,342,000 | $30,782,000 |
| Assets, Current | $4,775,000 | $4,394,000 | $7,909,000 | $4,109,000 |
| Long-term Debt and Lease Obligation | $19,831,000 | $17,494,000 | $17,353,000 | $13,150,000 |
| Goodwill | $1,964,000 | $1,964,000 | $0 | $0 |
| Intangible Assets, Net (Excluding Goodwill) | $5,470,000 | $4,806,000 | $4,463,000 | $4,463,000 |
| Other Assets, Noncurrent | $2,051,000 | $1,911,000 | $2,395,000 | $2,333,000 |
| Long-term Debt and Lease Obligation, Current | $157,000 | $412,000 | $88,000 | $56,000 |
| Accounts Payable, Current | $1,134,000 | $749,000 | $1,508,000 | $1,035,000 |
| Deferred Revenue, Current | $647,000 | $861,000 | $1,005,000 | $999,000 |
| Liabilities, Current | $3,534,000 | $3,639,000 | $4,390,000 | $4,263,000 |
| Deferred Income Tax Liabilities, Net | $3,127,000 | $2,890,000 | $2,270,000 | $1,787,000 |
| Liability, Defined Benefit Plan, Noncurrent | $2,490,000 | $2,205,000 | $2,103,000 | $1,932,000 |
| Deferred Revenue, Noncurrent | $1,969,000 | $3,733,000 | $6,406,000 | $8,178,000 |
| Other Liabilities, Noncurrent | $2,650,000 | $3,071,000 | $2,937,000 | $2,960,000 |
| Deferred Credits and Other Liabilities, Noncurrent | $10,236,000 | $11,899,000 | $13,716,000 | $14,857,000 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $1,008,000 | $19,149,000 | $19,185,000 | $19,178,000 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-810,000 | $-723,000 | $-601,000 | $-564,000 |
| Retained Earnings (Accumulated Deficit) | $-17,907,000 | $-17,962,000 | $-19,701,000 | $-20,102,000 |
| Stockholders' Equity Attributable to Parent | $417,000 | $464,000 | $-1,117,000 | $-1,488,000 |
| Employee-related Liabilities, Current | $696,000 | $716,000 | $854,000 | $654,000 |
| Taxes Payable, Current | $251,000 | $272,000 | $279,000 | $755,000 |
| Operating Lease, Liability, Current | $268,000 | $253,000 | $266,000 | $289,000 |
| Interest Payable, Current | $168,000 | $197,000 | $149,000 | $176,000 |
| Other Liabilities, Current | $209,000 | $179,000 | $203,000 | $299,000 |
| Disposal Group, Including Discontinued Operation, Liabilities, Current | $4,000 | — | $38,000 | $0 |
| Accounts Receivable, Allowance for Credit Loss, Current | $67,000 | $59,000 | $67,000 | $45,000 |
| Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization | — | — | $23,744,000 | $24,377,000 |
| Preferred Stock, Shares Authorized | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
| Preferred Stock, Shares Issued | 7,000 | 7,000 | 7,000 | 7,000 |
| Common Stock, Shares Authorized | 2,200,000,000 | 2,200,000,000 | 2,200,000,000 | 2,200,000,000 |
| Common Stock, Shares, Issued | 1,008,486,000 | 1,014,768,000 | 1,025,446,000 | 1,030,122,000 |
| Operating Lease, Right-of-Use Asset | $1,230,000 | $1,119,000 | $1,291,000 | $1,291,000 |
| Finance Lease, Right-of-Use Asset, after Accumulated Amortization | $260,000 | $236,000 | $216,000 | $216,000 |
| Finance Lease, Liability, Current | $16,000 | $17,000 | $19,000 | $19,000 |
| Operating Lease, Liability, Noncurrent | $1,040,000 | $959,000 | $1,113,000 | $1,113,000 |
| Finance Lease, Liability, Noncurrent | $215,000 | $198,000 | $183,000 | $183,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $941,000 | $-348,000 | $-886,000 | $308,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $1,014,000 | $738,000 |
| Net Income (Loss) Attributable to Parent | $-10,298,000 | $-55,000 | $-1,739,000 | $-1,024,000 |
| Net Cash Provided by (Used in) Operating Activities | $2,160,000 | $4,333,000 | $4,738,000 | $5,367,000 |
| Payments to Acquire Productive Assets | $3,100,000 | $3,231,000 | $4,367,000 | $4,530,000 |
| Proceeds from Divestiture of Businesses | $1,746,000 | $15,000 | $0 | $0 |
| Proceeds from Sale of Productive Assets | $165,000 | $366,000 | $47,000 | $37,000 |
| Payments for (Proceeds from) Other Investing Activities | $12,000 | $-20,000 | $-15,000 | $-9,000 |
| Net Cash Provided by (Used in) Investing Activities | $-1,201,000 | $-2,830,000 | $-4,305,000 | $493,000 |
| Proceeds from Issuance of Long-term Debt | $0 | $1,325,000 | $8,158,000 | $5,625,000 |
| Repayments of Long-term Debt | $185,000 | $2,678,000 | $8,818,000 | $10,787,000 |
| Proceeds from (Repayments of) Lines of Credit | $200,000 | $-200,000 | $0 | $0 |
| Payments of Dividends | $11,000 | $3,000 | $1,000 | $1,000 |
| Proceeds from (Payments for) Other Financing Activities | $-22,000 | $-12,000 | $-13,000 | $-37,000 |
| Net Cash Provided by (Used in) Financing Activities | $-18,000 | $-1,851,000 | $-1,319,000 | $-5,552,000 |
| Income Taxes Paid, Net | $1,303,000 | $-242,000 | $18,000 | $-125,000 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $1,138,000 | $1,245,000 | $1,219,000 | $914,000 |
| Notes Issued | $924,000 | $0 | — | — |
| Cash and Cash Equivalents, at Carrying Value | $2,234,000 | $1,889,000 | $1,003,000 | $728,000 |
| Restricted Cash, Current | $4,000 | $2,000 | $3,000 | $4,000 |
| Restricted Cash, Noncurrent | $10,000 | $9,000 | $8,000 | $6,000 |
| Depreciation, Depletion and Amortization | $2,985,000 | $2,956,000 | $2,749,000 | $2,680,000 |
| Gain (Loss) on Disposition of Business | $-121,000 | $-17,000 | $0 | $565,000 |
| Goodwill, Impairment Loss | $10,693,000 | $0 | $628,000 | $0 |
| Impairment of Long-Lived Assets to be Disposed of | $10,693,000 | $83,000 | $109,000 | $109,000 |
| Deferred Income Taxes and Tax Credits | — | — | $-705,000 | $-780,000 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $100,000 | $72,000 | $70,000 | $46,000 |
| Gain (Loss) on Extinguishment of Debt | $618,000 | $348,000 | $-740,000 | $-689,000 |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | $205,000 | $0 | $0 |
| Unrealized Gain (Loss) on Investments | $-97,000 | $-10,000 | $0 | $0 |
| Share-based Payment Arrangement, Noncash Expense | $52,000 | $29,000 | $48,000 | $57,000 |
| Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits | $-1,000 | $-181,000 | $30,000 | $-99,000 |
| Increase (Decrease) in Deferred Revenue | — | $1,763,000 | $2,673,000 | $3,727,000 |
| Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | $-730,000 | $-655,000 | $525,000 | $529,000 |
| Other Operating Activities, Cash Flow Statement | $20,000 | $-107,000 | $78,000 | $1,000 |
| Increase (Decrease) in Accounts Receivable | $-102,000 | $-19,000 | $168,000 | $156,000 |
| Increase (Decrease) in Accounts Payable | $-97,000 | $-202,000 | $632,000 | $140,000 |
| Increase (Decrease) in Accrued Taxes Payable | $-1,185,000 | $-189,000 | $20,000 | $860,000 |
| Increase (Decrease) in Other Current Assets and Liabilities, Net | $549,000 | $-304,000 | $-98,000 | $-211,000 |
| Interest Paid, Capitalized, Investing Activities | $111,000 | $176,000 | $154,000 | $165,000 |
| Operating Lease, Payments | $461,000 | $427,000 | $412,000 | $412,000 |
| Finance Lease, Interest Payment on Liability | $12,000 | $11,000 | $10,000 | $10,000 |
| Finance Lease, Principal Payments | $25,000 | $17,000 | $18,000 | $18,000 |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | $143,000 | $191,000 | $406,000 | $406,000 |
| Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | $10,000 | $2,000 | $6,000 | $6,000 |
| Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One | $2,000 | $2,000 | $2,000 | $2,000 |
| Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Five | $2,000 | $1,000 | $1,000 | $1,000 |
| Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five | $6,000 | $5,000 | $5,000 | $5,000 |